Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Dec;6(4):469-479.
doi: 10.1007/s13300-015-0129-8. Epub 2015 Sep 9.

Number-Based Approach to Insulin Taxonomy

Affiliations

Number-Based Approach to Insulin Taxonomy

Sanjay Kalra et al. Diabetes Ther. 2015 Dec.

Abstract

This article describes a number-based system for the classification of insulin regimes. It utilizes a patient-centered variable (number of injections per day) and pharmacokinetic/dynamic characteristics to craft a taxonomic system that is able to incorporate all available insulin preparations and coformulations. This framework of systematics is robust enough to include various molecules that have been recently developed. It serves to enhance understanding of the subject, and facilitates the practical or clinical usage of theoretical knowledge. We propose that number-based insulin taxonomic models should be used in clinical guidelines and recommendations rather than restricting ourselves to pharmaceutical-based classifications. PubMed articles including both review articles and clinical trials published since the year 1990 were searched, to gather evidence and information on the various types of insulins available, and how they can be used, based on the number or frequency of injections prescribed per day.

Keywords: Aspart; Basal insulin; BiAsp; Coformulation of insulin; Degludec; Glargine; Glulisine; IDegAsp; IDegLira; Insulin; Intensive insulin; Lispro; LisproMix; LixiLan; Premixed insulin; U300.

PubMed Disclaimer

Similar articles

Cited by

  • Expert Opinion: Patient Selection for Premixed Insulin Formulations in Diabetes Care.
    Kalra S, Czupryniak L, Kilov G, Lamptey R, Kumar A, Unnikrishnan AG, Boudiba A, Abid M, Akanov ZA, Latheef A, Araz M, Audehm R, Bahendeka S, Balde N, Chaudhary S, Deerochanawong C, Fasanmade O, Iraqi H, Latt TS, Mbanya JC, Rodriguez-Saldana J, Hyun KS, Latif ZA, Lushchyk M, Megallaa M, Naseri MW, Bay NQ, Ramaiya K, Randeree H, Raza SA, Shaikh K, Shrestha D, Sobngwi E, Somasundaram N, Sukor N, Tan R. Kalra S, et al. Diabetes Ther. 2018 Dec;9(6):2185-2199. doi: 10.1007/s13300-018-0521-2. Epub 2018 Nov 3. Diabetes Ther. 2018. PMID: 30390228 Free PMC article. Review.
  • Flexibility in insulin prescription.
    Kalra S, Gupta Y, Unnikrishnan AG. Kalra S, et al. Indian J Endocrinol Metab. 2016 May-Jun;20(3):408-11. doi: 10.4103/2230-8210.180003. Indian J Endocrinol Metab. 2016. PMID: 27186563 Free PMC article.

References

    1. Maiti R, Alloza JL. Social pharmacology: expanding horizons. Indian J Pharmacol. 2014;46:246–50. - PMC - PubMed
    1. Kalra S, Gupta Y. Social pharmacology and diabetes. Indian J Pharmacol. 2014;46:564. doi: 10.4103/0253-7613.140601. - DOI - PMC - PubMed
    1. Inzucchi S, Bergenstal R, Buse J, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycemia in type 2 diabetes, 2015: a patient centered approach update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2015;38:140–149. doi: 10.2337/dc14-2441. - DOI - PubMed
    1. Kalra B, Kalra S. Choosing an insulin analogue regime. Internet J Geriatr Gerontol. 2009;5(2). https://ispub.com/IJGG/5/2/11006. Accessed 7 Sep 2015.
    1. Zinman B, Philis-Tsimikas A, Cariou B, Handelsman Y, Rodbard HW, Johansen T, et al. Insulin degludec versus insulin glargine in insulin-naive patients with type 2 diabetes: a 1-year, randomized, treat-to-target trial (BEGIN Once Long) Diabetes Care. 2012;35(12):2464–2471. doi: 10.2337/dc12-1205. - DOI - PMC - PubMed

LinkOut - more resources